DCTs

Patients

Unifying observational research with a next-generation virtu...

Observational research is core to drug development, helping researchers understand the natural history of diseases and the real-world impact of treatments on patients.

R&D

How Japan is pioneering the future of oncology clinical tria...

Discover how Japan is leading the way in oncology clinical trials through the implementation of decentralised clinical trials

Digital

Female Research Scientist with Bioengineer

Initial leap of faith inspires today’s fast-growing digital ...

Explore how Tufts Center for the Study of Drug Development has spearheaded the growth of digital clinical trials through an initial leap of faith

Patients

How to advance diversity, equity and inclusion in clinical t...

The principles of diversity, equity and inclusion (DEI) are now a commonplace expectation in our world, positively impacting everything, from workplaces to classrooms to hospital halls.

R&D

How Chiesi is walking the walk on pharma sustainability

In an age of greenwashing, where ESG (environmental, social, governance) increasingly feels like a corporate buzzword, how do you find the companies that are not only talking the talk, but

R&D

Take the hybrid road to bring clinical trials to patients

As the landscape of clinical trials evolves, decentralised clinical trials (DCTs) have emerged to put patients at the centre of the research process.